Loading...
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
PDE4 inhibitors can suppress a variety of inflammatory cell functions that contribute to their anti-inflammatory actions in respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma. The systemically delivered PDE4 inhibitor roflumilast has been approved for use in a subset o...
Saved in:
| Published in: | Front Pharmacol |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080983/ https://ncbi.nlm.nih.gov/pubmed/32226383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00259 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|